Growth Metrics

CorMedix (CRMD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to -$190.6 million.

  • CorMedix's Retained Earnings rose 4602.15% to -$190.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.6 million, marking a year-over-year increase of 4602.15%. This contributed to the annual value of -$339.6 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Retained Earnings stood at -$190.6 million, which was up 4602.15% from -$299.2 million recorded in Q2 2025.
  • CorMedix's 5-year Retained Earnings high stood at -$190.6 million for Q3 2025, and its period low was -$353.1 million during Q3 2024.
  • Moreover, its 5-year median value for Retained Earnings was -$280.6 million (2022), whereas its average is -$281.7 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 1787.2% in 2024, then surged by 4602.15% in 2025.
  • CorMedix's Retained Earnings (Quarter) stood at -$245.7 million in 2021, then dropped by 12.09% to -$275.4 million in 2022, then decreased by 11.47% to -$306.9 million in 2023, then dropped by 10.65% to -$339.6 million in 2024, then skyrocketed by 43.88% to -$190.6 million in 2025.
  • Its Retained Earnings stands at -$190.6 million for Q3 2025, versus -$299.2 million for Q2 2025 and -$319.0 million for Q1 2025.